Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Phase I Trial Using Combination Irinotecan and Thalidomide for Recurrent CNS Tumors

This study has been completed.
Information provided by:
University of New Mexico Identifier:
First received: November 8, 2005
Last updated: January 6, 2010
Last verified: October 2008
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2006
  Primary Completion Date: June 2006 (Final data collection date for primary outcome measure)